Niccolo Pengo

Company: Mabylon
Job title: Chief Scientific Officer
Seminars:
Novel Antibodies Targeting the Inflammasome to Treat Neurodegeneration 2:30 pm
Discuss how the inflammasome is a promising target in neurodegenerative diseases Learn how abylon has identified novel monoclonal antibodies that hold promise for the treatment of neurodegenerationRead more
day: Day 2 - Track A - Afternoon